正在加载视频...

视频加载失败

Today, the AMA joined the Vaccine Integrity Project in announcing the completion of an independent, vaccine evidence review process for the 2026–27 respiratory virus season. The Vaccine Integrity Project conducted a thorough scientific review of RSV, flu, and COVID-19 vaccines — examining the risks and benefits. The evidence showed...

142,688 次观看 • 2 天前 •via X (Twitter)

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

Top-Tier Journal Confirms Mechanism of COVID-19 Vaccine-Induced Heart Damage The conversation around vaccines is shifting, with HHS emphasizing informed consent over mandates. This new approach is having a direct market impact, with recent reports showing Pfizer and Moderna COVID-19 vaccine sales tumbling. The reason? The public is increasingly examining the science. A landmark study published in Circulation, the flagship journal of the American Heart Association and a top-tier cardiovascular publication, has delivered a critical finding. The research identifies the precise mechanism behind myocarditis and pericarditis following mRNA vaccination. Here is the breakdown in plain English: The study reveals that in certain susceptible individuals, the immune system's T cells—trained by the vaccine to attack the SARS-CoV-2 spike protein—also mistakenly attack similar-looking proteins in heart tissue. This phenomenon, known as "molecular mimicry," means the body's defenses cannot reliably distinguish the virus from the heart itself, leading to an autoimmune attack on the cardiac muscle. Crucially, the study found this specific, expanded immune response in patients with post-vaccine myopericarditis, but not in those who had developed myocarditis from a natural COVID-19 infection. The implications are profound. This is no longer a debate based on epidemiological signals or VAERS data. A leading mainstream medical journal has published a study pinpointing a direct autoimmune mechanism for vaccine-induced heart damage that is distinct from the damage caused by the virus. With this level of evidence now in the public domain, the call for a science-driven reassessment of vaccine policies has never been stronger. The argument has moved from the fringe to the forefront of established medical literature. The question now is: What will it take for health authorities to officially acknowledge these findings and adjust their recommendations accordingly?

Camus

12,300 次观看 • 9 个月前

The FDA has approved Moderna's mRNA flu vaccine, the first flu shot using mRNA technology to reach the US market. The approval comes months after the same agency refused to even file Moderna's original application. Vinay Prasad, who took over the FDA's biologics division after Peter Marks, rejected the initial application in writing, citing the trial as not adequate and well controlled. His internal memo to FDA staff, later leaked to the Washington Post, called the annual flu vaccine framework an evidence-based catastrophe of low quality evidence, poor surrogate assays, and uncertain effectiveness measured with poor methods. Twelve former FDA chiefs responded by blasting his move to tighten vaccine standards in the New England Journal of Medicine. Prasad has since left the agency. ICAN submitted a letter to the FDA's independent VRBPAC committee before the vote laying out the problems: the vaccine was compared not against placebo but against a GSK product that Prasad himself called not best in class, the absolute influenza risk reduction was only 0.8% while the adverse reaction profile ran at 6.4%, the trial used a single season of data, and Part A of the trial produced more patient deaths than the comparator flu shot. The committee approved it anyway. Del Bigtree and Jefferey Jaxen walk through why this matters beyond the flu shot itself: mRNA technology, justified under COVID emergency conditions, is now entering the routine recommended schedule through a non-emergency approval, and will be the first mRNA product included in the vaccine injury compensation table. The flu shot is currently approved for adults 50 and older, fast-tracked for 65 and older.

The HighWire

18,826 次观看 • 13 天前